PARATEK PHARMACEUTICALS, INC. PRTK Income Statement

Paratek pharmaceuticals, inc. (PRTK)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
License and royalty revenue
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net revenue
22,866	16,544	24,594	20,710	18,705	17,117	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development collaborations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,294	4,342	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalty Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,697	1,474	1,246	1,258	776	0	0	0	-	-	-	-	-	-
Gross license fee revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,292	10,000	12,500	0	0	0
Gross milestone revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,000	0	0	0	-	-	-	-	-	-
Gross milestone revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Other Revenue, Net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	250	250	0	0	-	0	-	-	-	-
Advertising expense - Purdue Pharma
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,821	8,110	8,024	7,741	1,429	0	0	0	-	-	-	-	-	-
Net revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,074	-6,586	3,472	3,767	9,597	11,558	4,243	0	-	0	0	-	-	-
Expenses:
Cost of product revenue
4,749	3,484	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
34,551	39,554	42,223	49,913	54,036	57,508	59,930	56,002	56,279	60,072	65,551	70,773	77,829	83,460	78,966	79,449	68,312	50,765	38,206	21,390	11,229	5,014	4,117	5,526	5,587	6,904	8,069	8,716	10,677	11,191	11,624	11,235	11,139	11,273	10,807	10,546	0	0	0
Selling, general and administrative
89,457	89,135	93,135	83,109	75,101	63,658	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	36,965	31,808	29,538	28,424	26,400	25,531	25,377	22,056	19,988	16,330	12,609	9,666	5,848	7,806	8,390	10,082	12,431	10,755	10,580	10,281	10,263	12,138	12,574	12,425	12,185	11,029	10,879	0	0	0
Impairment of intangible assets
-	-	-	-	-	-	0	0	-	-	-	0	-	-	-	-	-	2,860	2,761	2,761	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in fair value of contingent consideration
-	-	-	-	-	-71	-70	-81	-368	-584	-866	-1,014	-681	-345	-630	-700	-315	-3,560	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes receivable impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
128,757	132,173	137,075	133,791	129,394	121,202	110,090	100,739	97,129	97,196	97,175	99,979	105,572	109,515	103,966	104,225	90,152	70,053	55,595	35,298	21,794	12,140	11,923	13,916	18,631	22,297	21,786	22,258	20,958	21,454	23,762	23,809	23,564	23,458	21,836	21,425	0	0	0
Loss from operations
-105,891	-115,629	-112,481	-113,081	-110,689	-104,085	-104,918	-95,605	-84,521	-84,580	-89,602	-92,418	-105,525	-109,486	-103,966	-104,225	-90,152	-70,053	-51,595	-31,298	-17,500	-7,798	-11,405	-13,016	-17,827	-27,371	-28,372	-18,786	-17,191	-11,857	-10	-9,872	-6,995	-3,764	-11,836	-8,925	0	0	0
Other income and expenses:
Interest income
3,333	3,574	3,842	3,772	3,731	3,260	2,690	2,157	1,612	1,377	1,259	1,179	1,118	1,069	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Interest expense
18,003	16,403	14,968	13,791	12,704	10,985	9,207	7,232	5,454	5,079	4,521	3,933	3,625	3,223	3,066	2,293	1,500	770	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) gain on mark-to-market of notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-120	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other gains (losses), net
0	-	-106	-82	0	-	-23	-19	-33	-34	0	0	0	-	0	0	-	-37	3	0	0	-	0	0	-	-75	-93	-121	-148	-159	-156	-140	-123	-116	-129	-143	0	0	0
Net loss before provision for income taxes
-	-	-123,713	-123,182	-	-111,854	0	0	0	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for income taxes
-	-	502	502	-	502	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other loss, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-120,797	-128,790	-124,215	-123,684	-120,216	-112,356	-111,458	-100,699	-89,149	-89,069	-93,631	-95,935	-108,035	-111,636	-106,289	-106,082	-91,498	-70,860	-60,874	-40,686	-27,257	-17,835	-12,249	-13,719	-18,157	-27,446	-28,465	-18,907	-17,339	-12,016	-166	-10,012	-7,118	-3,880	-11,943	-9,013	0	0	0
Unaccreted dividends on convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,927	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-19,762	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash distribution declared per common share (usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
Earnings Per Share, Basic (usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.37	-	-	-	-
Earnings Per Share, Diluted (usd per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.37	-	-	-	-
Weighted Average Number of Shares Outstanding, Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,522	-	-	-	-
Weighted Average Number of Shares Outstanding, Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,522	-	-	-	-
Other comprehensive loss
Unrealized gain on available-for-sale securities, net of tax
399	202	477	442	251	30	-249	-130	-125	-142	-94	-130	-55	-16	0	0	0	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,488	13,461	13,426	13,402
Comprehensive loss
-120,398	-128,588	-123,738	-123,242	-119,965	-112,326	-111,707	-100,829	-89,274	-89,211	-93,725	-96,065	-108,090	-111,652	-106,275	-106,048	-91,497	-70,860	0	0	0	-	-	-	-	-27,431	-28,439	-18,914	-17,332	-12,038	-197	-10,055	-7,135	-3,853	0	0	0	-	-
Net loss per share:
Basic and diluted net loss per common share
-0.66	-0.81	-1.00	-1.02	-1.10	-0.71	-1.01	-0.94	-0.91	-0.75	-0.77	-0.66	-1.14	-1.00	-1.04	-1.69	-1.78	-1.26	-1.33	-0.96	-0.74	42.96	-29.48	-42.23	20.93	-0.29	-0.25	-0.36	-0.56	-	-	-	-	-	-	-0.17	-0.14	-0.21	-0.15
Weighted average common stock outstanding Basic and diluted
41,641	33,796	32,590	32,446	32,334	32,162	31,742	31,581	30,566	27,988	27,776	27,347	24,196	22,873	22,627	17,895	17,615	17,655	17,561	16,372	14,418	9,840	135	71	67	18,842	18,782	18,757	18,703	-	-	-	-	-	-	-	-	-	-
Product Revenue, Net [Member]
Net revenue
17,473	11,517	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Government Contract Service Revenue [Member]
Net revenue
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration and Royalty Revenue [Member]
Net revenue
5,056	5,027	18,492	17,661	17,358	17,117	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-